Senior Faculty Scholars

Dr. David Glick is a Professor in the Department of Anesthesia & Critical Care. His clinical interests include the anesthetic management of vascular, thoracic and head and neck cancer patients as well as the care of patients in the Post-Anesthesia Care Unit (for which he has been the medical director since 2002). His research interests cover a wide range of clinical questions including the feasibility of processed EEG monitoring to decrease the risk of intra-operative awareness, the incidence of and risk factors for the development of deep venous clots around the time of surgery, ways to facilitate emergence from general anesthetics in children and patients for whom English is not the first language, the value and impact of surgical quality metrics, and the optimization of awake intubation techniques. He has published widely in these areas and students and residents in his lab have presented well over 100 abstracts at national and international meetings. He has received multiple awards for teaching and research mentorship and has been a track leader/cluster group leader for the clinical research tracks of the Pritzker Summer Research Program and the Scholarship & Discovery track for many years.

Dr. Golden is Associate Professor, Medical Student Clerkship Director, and Associate Residency Program Director in the Department of Radiation and Cellular Oncology. He completed residency at the University of Chicago. He is a graduate of the Pritzker School of Medicine Medical Education Research Innovation Teaching and Scholarship (MERITS) fellowship and completed a Masters of Health Professions Education (MHPE) at the University of Illinois at Chicago.

Dr. Golden’s clinical practice is at the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross where he treats a broad array of cancers with external beam radiation. Dr. Golden focuses on educating his patients about their disease and treatment process with the goal of reducing anxiety and improving treatment compliance and outcomes.

His academic interests focus on patient and trainee education. In 2017 Dr. Golden received a pilot grant from the Bucksbaum Institute to develop a graphic narrative discussion guide to help providers communicate to patients what to expect during the radiotherapy treatment process.  Along with additional extramural funding from the Radiation Oncology Institute and collaborators at The University of Chicago, IIT Institute of Design, UIC, and Harvard, he has since developed a series of seven Communicating the External Beam Radiotherapy Experience (CEBRE) guides and three Communicating the Gynecologic Brachytherapy Experience (CoGBE) guides. In addition, the CEBRE en Español guides are culturally appropriate translations of the original CEBRE guides in Spanish.  The discussion guides have been downloaded for use internationally.  Dr. Golden also founded the Radiation Oncology Education Collaborative Study Group (ROECSG), which develops, implements, and evaluates radiation oncology curricular innovations using a collaborative group study model. As of 2022 ROECSG has over 600 members representing more than 200 member institutions around the globe.  Dr. Golden enjoys spending time teaching and mentoring medical students and residents and he received the Radiation and Cellular Oncology Resident Physician teaching award in 2015. As of 2023, Dr. Golden has joined the Radiation Oncology staff at Rush University in Chicago, IL.

Dr. Fernando D. Goldenberg is an Associate Professor in the Departments of Neurology and Surgery (Neurosurgery) at the University of Chicago. He holds the positions of Director of Neuroscience Critical Care Medicine and Co-Director of the Comprehensive Stroke Center.

Dr. Goldenberg earned his medical degree from the University of Buenos Aires School of Medicine in Argentina. He then completed his Internal Medicine residency training in Argentina followed by training in Critical Care Medicine and a fellowship in Neurocritical Care at the Cleveland Clinic. He later joined the University of Chicago in 2002.

Dr. Goldenberg is a contributor to a wide range of research related to the care of critically ill neurological and neurosurgical patients. His current investigations focus on traumatic brain injury, brain death, prognostication after anoxic brain injury and the neurological complications of patients with implanted left ventricular assist devices.

His passion for teaching led him to develop a very successful online educational tool for physicians on Neurocritical Care and Stroke and is currently developing a similar one focused on nursing care.

An active speaker, Dr. Goldenberg has lectured on stroke and brain injury at medical meetings in the United States, Europe, and South America.

Dr. Perpetua Goodall is an Associate Professor of Obstetrics and Gynecology. She completed her undergraduate degree in Chemistry at Northwestern University. She graduated from Meharry Medical College and completed her residency in General Obstetrics and Gynecology at the University of Chicago. Immediately following residency, she joined the faculty in the OB/GYN department at the University of Chicago and has developed one of the largest clinical practices within the department. She is committed to providing comprehensive quality care for women throughout their reproductive lifespan from adolescence to menopause. She is particularly skilled in minimally invasive surgical techniques, including robotic and laparoscopic hysterectomies. She has been involved in clinical trials focusing on alternative treatment options for fibroids. As a respected clinical educator, Dr. Goodall is actively involved in both resident and medical student training and has received several teaching awards. She has held important leadership positions including Assistant Residency Program Director and Division Chief of General Obstetrics and Gynecology.

Dr. Goodall is now a Bucksbaum Senior Faculty Scholar.

Dr. Lawrence Gottlieb is an internationally known reconstructive plastic surgeon. Dr. Gottlieb’s clinical and research interests include: reconstructive microsurgery, the care of patients with burn injuries, difficult wounds, complex reconstructive needs, as well as challenging clinical medical and surgical ethical problems.

Dr. Gottlieb joined the faculty at the University of Chicago in 1984 and is currently Professor of Surgery, Director of the Burn and Complex Wound Center, and a faculty member of the MacLean Center for Clinical Medical Ethics. He works with many different multidisciplinary teams to provide comprehensive state-of-art treatment to a wide variety of patients.

Dr. Gottlieb is an ardent supporter of resident education and academic achievement. He is currently Vice President of The American Society for Reconstructive Microsurgery and has received many honors and awards including: the Department of Surgery ‘Excellence in Teaching Award’, The Section of Plastic Surgery ‘Robert Parsons Golden Apple Teaching Award’, The Illinois Society of Plastic Surgeons ‘Physician Recognition Award’ and ‘Distinguished Physician Award’ as well as the University of Chicago Biological Sciences Division ‘Distinguished Clinician Award’.

Jon E. Grant, MD, JD, MPH is a Professor of Psychiatry & Behavioral Neuroscience at the University of Chicago where he directs a clinic and research lab on addictive, compulsive and impulsive disorders. Dr. Grant’s research has been funded by the NIMH, NIDA, and private foundations. Dr. Grant received his BSA from the University of Michigan, an MA from the University of Chicago, his JD from Cornell University, an MD from Brown University, and his MPH from Harvard University. Dr. Grant is the author of over 400 peer-reviewed scientific articles, 15 books, is on the editorial board of 8 journals, and is the editor in chief of the Journal of Gambling Studies.

Olwen Hahn, MD, specializes in the diagnosis and treatment of breast cancer and genitourinary malignancies, including bladder, kidney, prostate and testicular cancers.

In addition to her clinical roles, Dr. Hahn serves as the primary investigator on multiple studies that examine the effectiveness of new drugs in breast cancer and renal cancer. She also is a dedicated educator, teaching medical students and post-graduate trainees on a variety of topics, including how to take a medical history and the importance of effective communication between doctors and patients.

Dr. Hahn has authored numerous articles in scientific journals, and has contributed to a leading textbook on molecular targeting in oncology. In 2011, Dr. Hahn was the recipient of the University of Chicago’s Distinguished Clinician Award.

Dr. Hahn is now a Bucksbaum Senior Faculty Scholar.

2012 Pilot Grant Project: Communication Skills Training Program for Oncology Trainees

Dr. Haraf is the Professor of Radiation & Cellular Oncology and the Medical Director of Radiation Oncology. Dr. Daniel Haraf is an expert in the treatment of lung, esophageal, and head and neck cancer. He was instrumental in pioneering the use of intensity modulated radiation therapy (IMRT)—a highly precise form of three-dimensional conformal radiotherapy. IMRT uses computers to accurately plan and deliver radiation with the fewest possible side effects for patients.

He has become a nationally recognized leader in the treatment of head and neck cancer (HNC). Dr. Haraf has been a major force in developing a program using chemotherapy together with IMRT in the treatment of patients with HNC—reducing or eliminating the need for extensive, debilitating, or mutilating surgery. This program has a long track record curing cancer with preservation of normal organ function as documented in the medical literature. Dr. Haraf is proud that we can actually discuss the expected results with our patients based on detailed analyses of our own treatment program.

Dr. Haraf has also pioneered re-irradiation for patients with recurrent cancer of the head and neck. People with recurrent cancer after radiation often have limited treatment options and little chance of cure. Most radiation oncologists will not consider offering a second round of radiation treatment. Dr. Haraf has found that re-irradiation is possible and offers these people their only chance of cure.

He is active in developing new methods of radiation delivery for patients with lung and esophageal cancer. Cancers in the chest can move while people breathe during treatment. We now have the technology to time the delivery of radiation to a specific part of respiration. The result is greater accuracy in treating the cancer while limiting the amount of normal lung tissue exposed to radiation.

Dr. Rex Haydon is a Professor in the Department of Orthopaedic Surgery & Rehabilitation Medicine and Associate Director of the Molecular Oncology Laboratory. Prior to entering medicine, Dr. Haydon was trained in archaeology and physical anthropology, culminating in a PhD in Anthropology in 1993. He then entered medical school, and completed residency training in orthopaedics, followed by fellowships in research and orthopedic oncology. Dr. Haydon has been a faculty member at the University of Chicago since 2003.

Dr. Haydon’s clinical focus is in the treatment of bone and soft tissue tumors of the extremities, and he is part of the Musculoskeletal Oncology Group at the University of Chicago. Dr. Haydon is a superb clinician who seeks to care for his tumor patients with less toxic treatment options, which has lead to identifying novel agents for the treatment of sarcomas and benign tumors.

He serves as the fellowship program director for musculoskeletal oncology.

Dr. Hightower is the Executive Vice President and Chief Digital Technology Officer (CDTO) of the University of Chicago Medicine, and the CEO and co-Founder of Equality AI. She is the former Chief Medical Information Officer (CMIO) and Sr. Director of Health Equity, Diversity, and Inclusion at the University of Utah Health and former CMIO and Chief Population Health Officer (CPHO) at University of Iowa Healthcare. Her executive leadership experience spans healthcare digital transformation strategy and operations, population health, and diversity, equity, and inclusion, with academic medical centers, clinically integrated networks, and accountable care organizations, and early-stage investor financed healthcare tech.

Dr. Hightower is an expert and a nationally sought speaker in Responsible AI and the intersection of digital technology with health equity, diversity, and inclusion. She strives to ensure that the value from digital transformation of healthcare is equitable across all stakeholders, including our most vulnerable.

In addition to leading digital strategy and operations at UChicago Medicine, she leads Equality AI, an early-stage investor backed healthcare tech startup. Equality AI is on a mission to end algorithmic bias in healthcare. Data scientists are the newest members of the care team. Equality AI empowers digitally enabled care teams to achieve health equity goals through responsible AI and tools to develop algorithms that address bias, fairness, and performance.
Dr. Hightower is a champion for health equity, diversity, and inclusion awareness and initiatives. She developed the Healthcare IT Equity Maturity Model (HITEM) to dismantle structural bias hardwired in healthcare IT and develop an inclusive and equity minded healthcare IT culture. Dr. Hightower was recently recognized by Health Data Management as one of the “Most Powerful Women in Healthcare IT” and “25 leading CMIOs at healthcare organizations.” She was recognized by Becker’s Hospital Review as one of “50 hospital and health system CMIOs to know”.

Dr. Hightower received her Medical Degree, as well as a Master of Public Health, from the University of Rochester School of Medicine, followed by residencies in Internal Medicine and Pediatrics at the University of California, San Diego. She also holds an MBA from the University of Pennsylvania’s Wharton School. Dr. Hightower has moved full-time in the CEO role for Equality AI.